Anti-Angiogenic Therapy in Ophthalmology
74,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
37 °P sammeln
  • Gebundenes Buch

This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book provides a concise overview over the pathology of retinal angiogenic diseases and explains why anti-angiogenic therapy is effective in so many patients. The reader is guided through the various clinical indications for anti-angiogenic therapy and made aware of its merits as well as current challenges and limitations. It is explained how, since its introduction for the treatment of exudative age-related macular degeneration in 2006, anti-angiogenic therapy has revolutionized the way in which we treat a range of ocular diseases. All of the authors are established experts in their respective fields who share their extensive knowledge and clinical experience with the reader. This book is both a valuable introduction to anti-angiogenic therapy in ophthalmology and a day-to-day companion for all ophthalmologists seeing patients with some of the most prevalent retinal diseases.

Autorenporträt
Andreas Stahl, MD, FEBO, graduated in Medicine from the University of Freiburg, Germany, in 2005. He spent the years 2008-2010 as a Research Fellow in the Department of Ophthalmology, Harvard Medical School, Boston, thanks to a DFG fellowship grant. Since 2011, Dr. Stahl has been Head of the Angiogenesis Research Group at the University Eye Hospital Freiburg, investigating the underlying mechanisms of angioproliferative retinal diseases. Clinically, Dr. Stahl works as a retinal surgeon attending to patients with a broad variety of retinal disorders ranging from retinopathy of prematurity to ischemic retinopathies and age-related maculopathy. Dr. Stahl has been the recipient of numerous awards, including the Innovative Research Award from the German Ophthalmic Society. He is a reviewer for many journals and author of more than 40 articles in peer-reviewed journals as well as several book chapters.